Investor Relations

Stock Quote (NASDAQ: PODD)

+ 0.11
Day High:
Day Low:
4:00 PM ET on Jan 18, 2017
Delayed ~20 min. By eSignal.
Stock price graph

Corporate Profile

Insulet Corporation is an innovative medical device company based in Billerica, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through its revolutionary Omnipod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy.

Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. Despite these benefits, most people still choose MDI therapy largely due to the complexity, cost and inconvenience of conventional..More ▼

View all »   RSSRecent Releases

Dec 20, 2016
Insulet Corporation to Present at Upcoming Investor Conference

Nov 16, 2016
Insulet Celebrates Milestone of 100,000 Customers Actively Using the Omnipod® System

View all »Events & Presentations

Jan 9, 2017 at 6:30 PM ET
35th Annual J.P. Morgan Healthcare Conference, San Francisco, California
Webcast Listen to webcast
PDF View Presentation  953.7 KB  

Nov 16, 2016 at 10:30 AM ET
Insulet Corporation Investor Day
Webcast Listen to webcast
PDF View Presentation   4.8 MB